Inside News

51 / 64

Radiation Oncology
Volume 12 No 3 I June 2016 51
The Faculty of Radiation Oncology
Genito-Urinary Group (FROGG)
Executive Committee has been busy
with a number of projects.
• Dr Kirsty Wiltshire is contributing
radiation therapy information to
the Prostate Cancer Foundation of
Australia website.
• Dr Amy Hayden continues to work
with the Urological Society of Australia
and New Zealand and the Medical
Oncology Group of Australia on
tripartite prostate cancer management
guidelines.
• A/Prof Kneebone is the FROGG
representative on the organising
committee for the Pan-Pacific Prostate
Conference in Melbourne later this
year.
• A/Prof David Christie has agreed to
be the convenor for the next FROGG
workshop titled ‘Relapse following
definitive treatment of prostate
cancer’. It will take place from 24-25
March 2017 so pop the dates in your
diary now.
On a sad note for us, A/Prof Margot
Lehman has decided to step down from
the FROGG Executive to concentrate
on her responsibilities as Chief Censor.
We would like to thank Margot for her
many years of service to our group.
Margot has helped organise many of
our conferences and is the first author
on a number of publications arising
from our FROGG workshops. Her quiet
assuredness, steadying influence and
willingness to help in any way will be
very much missed.
We are inviting applications for
membership of the FROGG Executive
Committee. If you have a GU
subspecialty interest and are willing to
contribute please write to legend.lee@
Also do not hesitate to
contact Andrew Kneebone (Andrew.
) or myself
) if you
would like more information about what
the role entails.
The Australian and New Zealand
Urogenital and Prostate Cancer Trials
Group (ANZUP) has enlisted FROGG’s
assistance in finding a representative for
ANZUP’s Scientific Advisory Committee
(SAC). Over the last four years A/
Prof Jarad Martin has made us proud
as the FROGG representative and
now needs to hand the reins over. Dr
Scott Williams is Chair of the Prostate
Subcommittee and is our other radiation
oncologist representative on the SAC.
As a consequence of Jarad standing
down, FROGG would like to put forward
a suitable nominee who would share
the research principles of ANZUP and
actively engage and contribute to
ANZUP’s research agenda. The main
purpose of the ANZUP SAC is to provide
a mechanism for the development of
new concept proposals, prioritisation
and incorporation of key translational
and research questions into active
and proposed trials. It also includes
the monitoring of ongoing trials and
establishing research priorities. The SAC
meets via teleconference three times
per year and has a face-to-face meeting
at the Annual Scientific Meeting (ASM).
Please contact Margaret McJannett,
Chief Executive Officer for more
information about the position
on or phone
+61 2 9562 5033. The FROGG executive
would like to finalise our nomination
to ANZUP by June in time for the
July ANZUP ASM.
Finally I would like to thank my
Co-Chair A/Prof Andrew Kneebone and
committee members David Christie,
Amy Hayden, Ben Hindson, Tom
Shakespeare, Mark Sidhom and Kirsty
Wiltshire for all their support and time
with continuing FROGG’s important
work.
Dr Marketa Skala
Co-Chair, FROGG
FROGG Executive Update
Member Participation
Opportunities
Membership of the FROGG
Executive Committee
If you have a GU subspecialty
interest and are willing to contribute
please write to legend.lee@ranzcr.
Also do not hesitate to
contact A/Prof Andrew Kneebone
au) or Dr Marketa Skala (Marketa.
) if you would
like more information about what
the role entails.